Hepatitis C screening in genitourinary clinic attendees

International Journal of STD and AIDS

Volumn 20, Issue 11, 2009, Pages 808-

  Kerr, R S ^a   Fernando, I ^b   Templeton, K ^c   Flynn, B ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Lauriston Building ^*  (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

COST EFFECTIVENESS ANALYSIS; FEMALE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LETTER; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MONEY; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; UROLOGY; CAUCASIAN; COST BENEFIT ANALYSIS; HOMOSEXUALITY; MASS SCREENING; PREVALENCE; STATISTICS; SUBSTANCE ABUSE; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS C; HOMOSEXUALITY, MALE; HUMANS; MALE; MASS SCREENING; PREVALENCE; RISK FACTORS; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 73949084893     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009295     Document Type: Letter

References (4)

1. Hutchinson SJ, Roy KM, Wadd S, et al. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges. Scott Med J 2006;51:8-15
2. Scottish Intercollegiate Guidelines Network. Guidelines 92: Management of Hepatitis C, December 2006. See [http://www.sign.ac.uk/pdf/sign92.pdf]
3. BASHH Clinical Effectiveness Group Guidelines. Sexually Transmitted Infections: UK National Screening and Testing Guidelines, August 2006. See [http://www.bashh.org/documents/59/59.pdf]
4. Roy KM, Goldberg DJ, Hutchinson S, et al. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users. J Med Virol 2004;74:62-6